![](/img/cover-not-exists.png)
A new promising risk stratifying tool based on combination of lymphovascular invasion and systemic immune-inflammation index to predict the survival and to help evaluate the potential benefit of adjuvant chemotherapy for upper tract urothelial carcinoma
Jan, H-C., Hu, C-Y., Yang, W-H., Ou, C-H.Volume:
19
Journal:
European Urology Open Science
DOI:
10.1016/S2666-1683(20)32773-7
Date:
July, 2020
File:
PDF, 85 KB
2020